Marksans Pharma Limited has initiated a Second 100 Day campaign called "Saksham Niveshak" pursuant to an Investor Education and Protection Fund Authority, Ministry of Corporate Affairs (MCA) letter. The campaign focuses on shareholder engagement to prevent transfer of unclaimed dividends to the Investor Education and Protection Fund (IEPF).
Key Objectives
- Enable shareholders to claim unclaimed dividends for Financial Year 2018-19 and subsequent years before transfer to IEPF
- Reach out to shareholders to update KYC details, contact details, bank account details, choice of nomination, and specimen signature
- Promote transparency and investor empowerment through direct claim processing without third parties
Documentation Requirements
Physical shareholders must submit relevant forms for registration or updating KYC details:
- Form ISR-1, ISR-2, ISR-3, SH-13, and SH-14
- Required supporting documents
- Forms available on RTA website (https://www.bigshareonline.com/) or company website (https://www.marksanspharma.com/forms.html)
Electronic shareholders must update details with their respective depository participants.
Unclaimed Dividends
According to company records, dividends declared from FY2019 to FY2025 have remained unclaimed for certain shareholders. Details of unclaimed dividends are available on the company website at https://www.marksanspharma.com/.
Deadline
The campaign has a submission deadline of June 17, 2026 for document submission and claims.